Exhibit 5.1

 

 

 

Attorneys at Law

 

641 Lexington Avenue | 14th Floor

New York, New York 10022

Dial: 212.335.0466

Fax: 917.688.4092

info@foleyshechter.com

www.foleyshechter.com

 

November 19, 2026

 

HeartSciences Inc.

550 Reserve Street, Ste 360

Southlake, TX 76092

 

Re: Registration Statement on Form S-3 (File No. 333-299147)

 

Ladies and Gentlemen:

 

We have acted as counsel to HeartSciences Inc., a Texas corporation (the “Company”), in connection with the proposed issuance and sale by the Company, from time to time, of up to $50,000,000 of shares (the “Shares”) of common stock, $0.001 par value per share (“Common Stock”), of the Company pursuant to that certain Equity Distribution Agreement (the “EDA”) with Maxim Group LLC, as sales agent under the Company’s Registration Statement on Form S-3 (File No. 333-299147) (as amended or supplemented from time to time, the “Registration Statement”) and the Prospectus Supplement, dated November 19, 2026 (the “Prospectus Supplement”), filed with the U.S. Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Act”) relating to the proposed issuance and sale of the Shares.

 

In connection with this opinion, we have examined originals or copies, certified or otherwise identified to our satisfaction, of: (i) the Company’s Certificate of Formation, as amended through the date hereof; (ii) the Company’s Bylaws, as amended through the date hereof; (iii) certain resolutions of the Company’s Board of Directors (the “Board”) relating to the issuance, sale and registration of the Shares; (iv) the Registration Statement, together with the exhibits thereto filed with the Commission; (v) the base prospectus included in the Registration Statement and Prospectus Supplement; (vi) such other document and records of the corporate proceedings of the Company and certificates of the Company’s officers as we have deemed relevant; and (vii) the EDA and the transactions contemplated thereby. As to various questions of fact material to this opinion, we have relied upon representations of officers or directors of the Company and documents furnished to us by the Company without independent verification of their accuracy.

 

In our examination of the foregoing documents, we have assumed without independent investigation the genuineness of all signatures, the legal capacity and competency of all natural persons, the authenticity of all documents submitted to us as originals and, the conformity to original documents of all documents submitted to us as copies, the authenticity of the originals of such latter documents and the legal competence of all signatories to such documents.

 

 

 

 

When relevant facts were not independently established, we have relied without independent investigation as to matters of fact upon statements of governmental officials and upon representations made in or pursuant to the Registration Statement and certificates or statements of appropriate representatives of the Company.

 

Based upon the foregoing, and subject to the assumptions, exceptions, qualifications and limitations set forth herein, and assuming the receipt of the appropriate consideration for the Shares, we are of the opinion that the Shares have been duly authorized, and when the Shares are issued against payment therefor as set forth in the Registration Statement and the Prospectus Supplement and in accordance with terms and conditions of the EDA, will be validly issued, fully paid and nonassessable.

 

We express no opinion herein as to the laws of any state or jurisdiction other than the laws of the State of New York, the Texas Business Organizations Code of the State of Texas and the federal laws of the United States of America.

 

We understand that you wish to file this opinion with the Commission as an exhibit to a Current Report on Form 8-K of the Company for incorporation by reference into the Registration Statement in accordance with the requirements of Item 601(b)(5) of Regulation S-K promulgated under the Securities Act and to reference the firm’s name under the caption “Legal Matters” in the Prospectus Supplement, and we hereby consent thereto. In giving this consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.

 

Please note that we are opining only as to the matters expressly set forth herein, and no opinion should be inferred as to any other matters. The Shares may be issued from time to time on a delayed or continuous basis, but this opinion is based upon currently existing statutes, rules and regulations and judicial decisions, and we disclaim any obligation to advise you of any change in any of these sources of law or subsequent legal or factual developments which might affect any matters or opinions set forth herein.

 

In rendering the foregoing opinion, we have assumed that the Company will comply with all applicable notice requirements regarding uncertificated shares provided by applicable law. This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Securities Act. It is understood that this opinion is to be used only in connection with the offer, sale, and issuance of the Shares while the Registration Statement is in effect.

 

Very truly yours,

 

/s/ Foley Shechter Ablovatskiy LLP